Deb Autor is our Chief Policy Officer, a role she assumed in November 2025. She has been a member of our board of directors since November 2024. Ms. Autor is also a Board Director of Amneal Pharmaceuticals, Inc. (AMRX) and Chair of the Board of the FDA Alumni Association. She has also served as CEO of strategic regulatory consulting firms Healthcare Innovation Catalysts, Inc. and Autor Strategies, LLC. Ms. Autor was previously a Board member of Pardes Biosciences, Inc. (PRDS); the Antimicrobial Resistance Industry Alliance; and the Parenteral Drug Association. She has also served as a Scientific Advisory Council Member of the Centre for Innovation in Regulatory Science and as an Advisory Board Member of the United States Pharmacopoeia Quality Institute. From 2019-2021, Ms. Autor was Global Head of Regulatory Excellence at AstraZeneca, where she led regulatory operations, policy and intelligence for AstraZeneca submissions globally. Before joining AstraZeneca, Ms. Autor served at Mylan N.V. from 2013-2019, where she was Head of Strategic Global Quality and Regulatory Policy and Head of Global Quality. Ms. Autor was a senior leader at the FDA from 2001-2013, most recently as Deputy Commissioner for Global Regulatory Operations and Policy where she oversaw all FDA inspections, criminal investigations and international operations for human and veterinary drugs, biologics, medical devices, tobacco and food. Before that, Ms. Autor served as Director of the Office of Compliance of the Center for Drug Evaluation and Research, leading enforcement and policy making for requirements relating to drug approval; current good manufacturing practices (GMP); human subject protection and bioresearch monitoring (GCP); pharmacy compounding; import and export; and recalls, among others. Before joining the FDA, Ms. Autor was a Trial Attorney in the Office of Consumer Litigation of the U.S. Department of Justice, where she litigated civil and criminal cases on behalf of the FDA. Ms. Autor received a Juris Doctor, Magna Cum Laude, from Boston University School of Law and a Bachelor of Arts in Psychology from Columbia University, Barnard College.